Ophidion
Latest round
- Seed
Last raised
- Oct 2019
Total raised
- $0.8M
Investors
- 5
About Ophidion
Based in Pennsylvania, US, Ophidion Inc. operates as an early-stage central nervous system (CNS) biopharmaceutical company focused on developing a pipeline to deliver gene silencing therapies to treat neurodegenerative diseases. In October 2022, Ophidion Inc. Ophidion Inc.g. Alzheimer’s disease, Parkinson’s disease), and Parkinson’s disease, Alzheimer’s disease, Frontotemporal Dementia, ALS, and Glioblastoma Multiforme. In addition, the company runs an analgesia program that involves a non-opioid mechanism of action and an anti-anxiety program coupled with genomic testing to treat various difficult-to-treat anxiety disorders.
Who invested in Ophidion
5 investors across 1 round
See all investors in Ophidion
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 3, 2019
Amount
$0.8M
Investors
Questions about Ophidion
Who invested in Ophidion?
Ophidion has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ophidion raised?
Ophidion has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ophidion last raise money?
Ophidion's most recent round on record is a Seed, in Oct 2019.
What does Ophidion do?
Based in Pennsylvania, US, Ophidion Inc.
Where is Ophidion headquartered?
Ophidion is headquartered in Bethlehem, US.
Which VCs invest in companies like Ophidion?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ophidion's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Ophidion? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.